A TI-RADS 5 result, or TR5, is the highest category in the ACR TI-RADS system and means your thyroid nodule is highly suspicious on ultrasound. It is understandably the most worrying category to see on a report. This guide explains what TR5 means, its cancer risk, and why prompt evaluation is recommended, while keeping the numbers in perspective.

What TR5 means

A nodule that totals 7 or more points across the five ultrasound features is classified as TR5. Reaching that score usually takes several suspicious features at once, such as a solid, very hypoechoic nodule that is taller-than-wide, has an irregular margin, or contains punctate echogenic foci.

TR5 is the category most strongly associated with thyroid cancer, which is why it has the lowest size threshold for biopsy.

TR5 malignancy risk

The estimated malignancy risk for a TR5 nodule is around 35 percent. That is the highest of any TI-RADS category, but it also means that roughly two out of three TR5 nodules still turn out to be benign. A TR5 result is a strong reason to evaluate the nodule promptly, not a diagnosis of cancer.

Category Points Suspicion Est. malignancy
TR4 4–6 Moderate ~9.1%
TR5 7+ High ~35%

When a TR5 nodule needs a biopsy

TR5 carries the most cautious thresholds:

  • 1.0 cm or larger — fine needle aspiration (FNA) biopsy is recommended.
  • 0.5 to 0.9 cm — annual follow-up ultrasound for up to 5 years.
  • Under 0.5 cm — usually monitored rather than biopsied, given the difficulty of sampling tiny nodules.

The TI-RADS calculator applies these thresholds to your nodule’s size automatically. To understand how the points build up, see the TI-RADS score guide.

For patientsA TR5 result is the one category where prompt follow-up really matters, so book the recommended biopsy or scan without delay. At the same time, keep in mind most TR5 nodules are still benign, and a biopsy is what provides a clear answer.

For clinicians: For subcentimeter TR5 nodules, weigh FNA against active surveillance and patient factors. Document the specific high-risk features driving the 7-plus score, as they influence surgical planning if malignancy is confirmed.

What happens after a TR5 biopsy

FNA sampling determines whether the nodule contains malignant cells. If cancer is confirmed, most thyroid cancers, particularly papillary carcinoma, are highly treatable, often with excellent long-term outcomes. Your care team will discuss options such as surgery and, in some cases, active surveillance. Features like a very hypoechoic appearance often contribute to a TR5 score.

Frequently asked questions

Does TI-RADS 5 mean I have cancer?
No. TR5 is highly suspicious with an estimated 35 percent malignancy risk, so about two thirds of TR5 nodules are still benign. A biopsy confirms the diagnosis.

What size TR5 nodule needs a biopsy?
Biopsy is generally recommended for TR5 nodules that are 1.0 cm or larger. Nodules from 0.5 to 0.9 cm are followed with annual ultrasound.

How urgent is a TR5 result?
TR5 warrants prompt evaluation, but it is not an emergency. Schedule the recommended biopsy or follow-up as advised by your doctor.